<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>617</id><JournalTitle>A REVIEW ON PREECLAMPSIA AND ITS TREATMENT STRATEGIES</JournalTitle><Abstract>Hypertensive Disorders of pregnancy are an important cause of severe morbidity, long-term disability and death
among both mothers and fetus. Among all the Hypertensive disorders that complicate Pregnancy, Pre-eclampsia and Eclampsia
are the major causes of maternal and perinatal mortality and morbidity. The etiology involved in development of preeclampsia
include genetic and immunological factors. Defective Placental implantation, failed maternal remodeling causes imbalance
between pro-angiogenic factors and anti-angiogenic factors leading to pre-eclampsia. The most preferred agents for treatment
of preeclampsia include labetalol, Nifedipine, Methyldopa, hydralazine etc. The appropriate selection of antihypertensive drug
is the major issue to be concerned in pre-eclampsia. Recent Guidelines of National Institute of Clinical Health and Excellence
for Hypertension in pregnancy suggests that the preferred choice of drug is Oral Labetalol to Oral nifedipine and Methyldopa</Abstract><Email>yogyapharmd@gmail.com</Email><articletype>Review</articletype><volume>6</volume><issue>5</issue><year>2015</year><keyword>Preeclampsia,Pregnancy,Labetalol,Nifedipine,Methyldopa</keyword><AUTHORS>Mandali Yogya sree Harshini,Chava Jhansi,Kanneganti Sandeep</AUTHORS><afflication>Department of Pharmacy Practice, Government General Hospital, Chalapathi Institute of Pharmaceutical Sciences, Guntur, Andhra Pradesh, India,Department of Pharmacy Practice, Government General Hospital, Chalapathi Institute of Pharmaceutical Sciences, Guntur, Andhra Pradesh, India,Department of Pharmacy Practice, Government General Hospital, Chalapathi Institute of Pharmaceutical Sciences, Guntur, Andhra Pradesh, India</afflication></Article></Articles>